SOPAX | VIVIX | SOPAX / VIVIX | |
Total Expense Ratio | 1.00 | 0.04 | 2,500% |
Annual Report Gross Expense Ratio | 1.00 | 0.04 | 2,500% |
Fund Existence | 33 years | 27 years | - |
Gain YTD | 7.134 | 7.866 | 91% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.86B | 203B | 4% |
Annual Yield % from dividends | 1.16 | 2.11 | 55% |
Returns for 1 year | 3.86 | 7.74 | 50% |
Returns for 3 years | 21.84 | 36.61 | 60% |
Returns for 5 years | 34.52 | 70.16 | 49% |
Returns for 10 years | 87.84 | 131.61 | 67% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
POIRX | 15.45 | 0.09 | +0.59% |
Polen International Growth Investor | |||
FSOPX | 15.98 | 0.08 | +0.50% |
Fidelity Series Small Cap Opps | |||
JGRSX | 13.27 | 0.06 | +0.45% |
JHancock Global Shareholder Yield R6 | |||
EXHAX | 26.81 | 0.11 | +0.41% |
Manning & Napier Pro-Blend Max Term S | |||
VIMAX | 358.38 | -0.51 | -0.14% |
Vanguard Mid Cap Index Admiral |